secwatch.observer — SEC 8-K summary
======================================

Issuer:     NKGen Biotech, Inc. (—)
CIK:        0001845459
Form:       8-K
Filed at:   2026-02-05T23:59:59+00:00
Accession:  0001213900-26-012879
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NKGen Biotech obtains additional $251K loan, secured note now $26.8M
--------------------------------------------------------------------

- Entered third amendment to secured promissory note with AlpineBrook Capital for additional $251,000 loan.
- Total principal amount of secured promissory note increased to $26,758,106.
- Interest on the new loan begins accruing from January 30, 2026, the funding date.
- Loan is part of a series of amendments; prior principal was $26,507,106 after second amendment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845459/000121390026012879/0001213900-26-012879-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845459/000121390026012879/ea0275350-8k_nkgen.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-012879

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer